Amgen announced it will present at the 2026 Wells Fargo Healthcare Conference on September 10, 2026, featuring top executives including CFO Thomas Dittrich and Chief Medical Officer Paul Burton. The presentation will be webcast live and available for replay for 90 days on Amgen's website, providing investors and the public access to updates on the company's business and pipeline. Amgen is a leading biotech firm known for innovative medicines targeting cancer, heart disease, and other serious conditions, and is part of major stock indices like the Dow Jones Industrial Average and Nasdaq-100. This event offers insight into Amgen's ongoing developments and strategic direction.
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting confidence in the biotechnology company's recent strong stock performance. Amgen's shares have outperformed the broader market and its sector, rising 2.6% recently whi...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
